Navigation Links
Milliman Announces Encore Webinar on Practical Uses of Lifestyle-Based Analytics (LBA) in Risk Selection
Date:6/3/2008

SEATTLE, June 3 /PRNewswire/ -- Due to its increasing potential as a tool in health insurance underwriting, Lifestyle-Based Analytics (LBA) continues to receive considerable attention from insurers and the media. We've probably all seen optimistic claims about the use of consumer data as a predictor in the underwriting process. In response, Milliman expert Jonathan Shreve, FSA, offers a fresh perspective on an advance in risk selection and classification through the effective use of Lifestyle-Based Analytics.

Studies and intuition tell us that lifestyle habits and characteristics are linked to disease prevalence. Through the use of consumer data, LBA utilizes lifestyle variables to enhance the risk classification system for relevant conditions. Statistics are then applied to identify correlations between lifestyle information and prevalence of various diseases. This has proven to be extremely effective in differentiating between high-cost and low-cost insurance plan members.

LBA is increasingly viewed as a high-quality advance in the art of risk selection. Within the last decade, the amount and reliability of data collected has grown dramatically. This enhanced data enables LBA researchers to identify risk pools that correlate to certain adverse conditions. It now appears likely that LBA could be used in conjunction with other risk classification tools to produce underwriting results with a meaningfully higher degree of accuracy.

As an early developer of LBA, Milliman has now completed a number of client projects involving its use. Due to a scheduling conflict for the webinar in May, Milliman will conduct an encore free educational Webinar on June 24th, at 2 PM EDT, to share the knowledge gained in the process, and to address both the potential for and limitations of LBA. The seminar will also explore meaningful underwriting applications of LBA. Highlights of the Webinar include:

-- Details of integrating LBA with traditional underwriting,

-- Conceptual evaluation of the methodology involved in building LBA

models, and

-- Further advances in risk selection.

Those interested in attending the Webinar should contact Jon Shreve at jon.shreve@milliman.com. Please include your contact details.

Milliman, whose corporate offices are in Seattle, serves the full spectrum of business, financial, government, and union organizations. Founded in 1947 as Milliman & Robertson, the company has 48 offices in principal cities in the United States and worldwide. Milliman employs more than 2,000 people, including a professional staff of more than 900 qualified consultants and actuaries. The firm has consulting practices in employee benefits, healthcare, life insurance/financial services, and property and casualty insurance. For further information visit http://www.milliman.com.


'/>"/>
SOURCE Milliman
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Milliman Survey Confirms Continued Dominance of Guarantees in Variable Annuity Retirement Income Products
2. Milliman Expert Addresses Practical Applications of Lifestyle-Based Analytics in Risk Selection
3. Milliman Says 2008 Medical Cost for American Family of Four Exceeds $15,600
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... Individuals who have been diagnosed ... surgery, treatment, therapy and management. Regular exercise in proper environments has been shown ... their diseases. On February 23, 2017, 1:00-2:00 p.m. E.S.T., a dynamic HydroWorx ...
(Date:2/21/2017)... NJ (PRWEB) , ... February 21, 2017 , ... ... research and conference coverage in veterinary medicine, will be launching its first bi-monthly ... animal health and medicine, business and practice management, and One Health. , ...
(Date:2/21/2017)... ... 2017 , ... Atlanta-based Jvion, the leading cognitive clinical science ... practice. Predixion, which raised $42M+ to date, received $20M in its third ... Ventures, and Software AG , will bring top industry talent and an impressive ...
(Date:2/21/2017)... ... February 21, 2017 , ... A February 6 article on Healio ... It found that the treatments have led to significant improvements in weight loss and ... efforts. It also noted very few problematic results relating to the treatment. Beverly Hills ...
(Date:2/20/2017)... Ill. (PRWEB) , ... February 20, 2017 , ... ... to reduce the rate at which women are called back for additional examinations ... journal Radiology . , In 2011, the U.S. Food and Drug Administration ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... MELBOURNE, Australia , Feb. 21, 2017  IBM (NYSE: ... IBM Watson,s ability to detect abnormalities of the eye,s retina. ... trained a research version of Watson to recognize abnormalities in ... insights and speed in their early identification of patients who ... glaucoma, a leading cause of blindness in the developed world. ...
(Date:2/21/2017)... Medical Oxygen Concentrators Market: Overview ... Medical oxygen concentrators are used by patients ... having low level of oxygen in their blood ... are to be used only with prescription and ... concentrators work either on rechargeable lithium batteries or ...
(Date:2/21/2017)...   BeyondSpring Pharmaceuticals , a clinical stage ... immuno-oncology cancer therapies, today announced that the Company,s ... 2 trial of BeyondSpring,s innovative lead asset, ... lung cancer (NSCLC) with Docetaxel has been selected ... Immuno-Oncology Symposium in Orlando, Fla. ...
Breaking Medicine Technology: